EU-Startups
Cambridge startup T-Therapeutics secures €27.5 million to improve how the immune system targets disease
T-Therapeutics, a British BioTech company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, today announced the successful expansion of its Series A […]
